trending Market Intelligence /marketintelligence/en/news-insights/trending/cdrmPnpI-mDPB6IfBHTKXA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Clinuvel Pharmaceuticals board member to retire

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Clinuvel Pharmaceuticals board member to retire

Clinuvel Pharmaceuticals Ltd said Elie Ishag will not stand for re-election as a nonexecutive director at the company's 2017 annual general meeting.

Ishag, who has been on the board since February 2011, will continue to serve until the date of the meeting.

Clinuvel said it is searching for a new director.